Abstract
Personality disorders (PDs) represent some of the most insidious and challenging psychiatric conditions that clinicians encounter, and often create unwarranted and unwanted conflicts in clinical settings. The reasons for these conflicts lie at the core of the PD pathology, namely, a fundamental impairment in interpersonal relationships that leads to a variety of maladaptive, inappropriate, or outrageous behaviors that the affected person seems incapable of fully understanding and controlling. Consider these examples:
-
1.
Vincent P. is a 78-year-old retired professor of English literature who is seen in an outpatient VA clinic. He has a consistent pattern of meeting a new doctor, asking repetitively for help with chronic headaches, and then cursing out and vilifying the doctor for failing to help him. On a regular basis he angrily demands meetings with the hospital administrator to complain about his current physician.
-
2.
Susan R. is a 24-year-old graduate student who presents to a neurology clinic complaining of muscle twitches, headache, paresthesias, and nervousness. The clinic’s staff notice numerous linear scars on her arms consistent with self-inflicted cutting. A thorough examination is unrevealing, and Susan is told that she should consider seeing a psychiatrist to help deal with stress. She becomes enraged at the neurologist, and accuses him of insensitivity and ignorance. She storms out of the office, cursing the physician and staff for misleading her.
-
3.
John D. is a 34-year-old man with multiple sclerosis who lives with his mother. He has never been married and has few friends. He has worked at odd jobs in the past but is currently on disability. He presents to a neurology clinic intermittently for follow-up, but is minimally communicative with staff and rarely compliant with treatment. During previous hospitalizations, nurses have described him as aloof, distant, and odd.
Keywords
- Personality Disorder
- Antisocial Personality Disorder
- Borderline Personality Disorder
- Divalproex Sodium
- Impulsive Aggression
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, revised (DSM-IV-TR). Washington DC: Amer Psychiatric Pub; 2000.
Weissman MM. The epidemiology of personality disorders: a 1990 update. J Personal Disord 1993;7:44–62.
Abrams RC, Horowitz SV. Personality disorders after age 50: a meta-analysis. J Personal Disord 1996;10:271–281.
Kunik ME, Mulsant BH, Rifai AH, et al. Personality disorders in elderly inpatients with major depression. Am J Geriatr Psychiatry 1993;1:38–45.
Oldham JM, Skodol AE, Kellman HD, et al. Comorbidity of Axis I and Axis II disorders. Am J Psychiatry 1995;152:571–578.
Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2004;65:948–958.
Agronin ME, Maletta G. Personality disorders in late life: understanding and overcoming the gap in research. Am J Geriatr Psychiatry 2000;8:4–18.
Cloninger CR. A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 1987;44:573–588.
Cloninger CR, Svrakic DM, Przybeck TR. A psychobiologic model of temperament and character. Arch Gen Psychiatry 1993;50:975–990.
Siever LJ, Davis KL. A psychobiological perspective on the personality disorders. Am J Psychiatry 1991;148:1647–1658.
Coccaro EF, Siever LJ, Klar HM, et al. Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 1989;46:587–599.
Stein DJ, Trestman RL, Mitropoulou V, Coccaro EF, Holander E, Siever LJ. Impulsivity and serotonergic function in compulsive personality disorder. J Neuropsychiatry Clin Neurosci 1996;8:393–398.
New AS, Siever LJ. Neurobiology and genetics of borderline personality disorder. Psychiatr Ann 2002;32:329–336.
Higley JD, Linnoila M. Low central nervous system serotonergic activity is traitlike and correlates with impulsive behavior. A nonhuman primate model investigating genetic and environmental influences on neurotransmission. Ann NY Acad Sci 1997;836:39–56.
Olds D, Henderson CR, Cole R, et al. Long-term effects of nurse home visitation on children’s criminal and antisocial behavior: 15-year follow-up of a randomized controlled trial. JAMA 1998;280:1238–1244.
Caspi A, McClay J, Moffitt TE, et al. Role of genotype in the cycle of violence in maltreated children. Science 2002;297:851–854.
Soloff PH. Psychobiologic prespectives on treatment of personality disorders J Personal Disord 1997;11:336–344.
Rubin EH, Morris JC, Berg L. The progression of personality changes in senile dementia of the Alzheimers type. J Am Geriatr Soc 1987;35:21–25.
Petry S, Cummings JL, Hill MA, Shapria J. Personality alterations in dementia of the Alzheimers type. Arch Neurol 1988;45:118–190.
Bozzola FG, Gorelick PB, Freels S. Personality changes in Alzheimer’s disease. Arch Neurol 1992;49:297–300.
Miner JH. Neuropsychological contributions to differential diagnosis of personality disorders in old age. In: Rosowsky E, Abrams RC, Zweig RA, eds. Personality Disorders in Older Adults. Emerging Issues in Diagnosis and Treatment. Mahwah: Erlbaum; 1999:189–204.
Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL. Cognitive-behavioral treatment of chronically suicidal borderline patients. Arch Gen Psychiatry 1991;48:1060–1064.
Linehan MM. Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York: Guilford Press; 1993.
Robins CJ. Dialectical behavior therapy for borderline personality disorder. Psychiatr Ann 2002;32:608–616.
Lynch TR. Treatment of elderly depression with personality disorder comorbidity using dialectical behavior therapy. Cog and Beh Practice 2000;7:447–456.
Livesley WJ. Treating the emotional dysregulation cluster of traits. Psychiatr Ann 2002;32:601–607.
Markovitz PJ. Pharmacotherapy. In: Livesly WJ, ed. Handbook of Personality Disorders. New York: Guilford Press; 2001:477–493.
Markovitz PJ. Recent trends in the pharmacotherapy of personality disorders. J Personal Disord 2004;18:90–101.
Solomon, K. Personality disorders and the elderly. In: Lion JR, ed. Personality Disorders, Diagnosis and Management. Baltimore: Williams & Wilkins; 1981:310–338.
Straker, M. Adjustment disorders and personality disorders in the aged. Psychiatr Clin North Am 1982;5:121–129.
McGlashen TH. Schizotypal personality disorder. The Chestnut Lodge follow-up study: IV. Long-term follow-up perspectives. Arch Gen Psychiatry 1986;43:329–334.
Goldberg SC, Schulz SC, Schulz PM, Resnick RJ, Hamer RM, Freidel, RO. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo. Arch Gen Psychiatry 1986;43:680–686.
Hymowitz P, Frances A, Jacobsberg LB, Sickles M, Hoyt R. Neuroleptic treatment of schizotypal personality disorder. Compr Psychiatry 1986;27:267–271.
Schulz SC. The use of low-dose neuroleptics in the treatment of “schizo-obsessive” patients. Am J Psychiatry 1986;143:1318–1319.
Koenigsberg HW, Reynolds D, Goodman M, et al. Risperidone in the treatment of schizotypal personality disorder. J Clin Psychiatry 2003;64:628–634.
Jensen HV, Anderson J. An open, comparative study of amoxapine in borderline disorders. Acta Psychiatr Scand 1989;79:89–93.
Markovitz PJ, Calabrese JR, Schulz SC, Meltzer HY.. Fluoxetine treatment of borderline and schizotypal personality disorders. Am J Psychiatry 1991;148:1064–1067.
Robins LN, Helzer JE, Weissman MM, et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984;41:949–958.
Blazer DG, George LK, Landerman R, et al. Psychiatric disorders, a rural/urban comparison. Arch Gen Psychiatry 1985;42:651–656.
Black DW, Baumgard CH, Bell SE. A 16-to 45-year follow-up of 71 men with antisocial personality disorder. Compr Psychiatry 1995;36:130–140.
Hirose S. Effective treatment of aggression and impulsivity in antisocial personality disorder with risperidone. Psychiatry Clin Neurosci 2001;55:161–162.
Penick EC, Powell BJ, Campbell J, et al. Pharmacological treatment for antisocial personality disorder in alcoholics: a preliminary study. Alcohol Clin Exp Res 1996;20:477–484.
Arndt IO, McLellan AT, Dorozynsky L, Woody GE, O’Brien CP. Desipramine treatment for cocaine dependence. Role of antisocial personality disorder. J Nerv Ment Dis 1994;182:151–156.
Gunderson JG, Carpenter WT, Strauss JS. Borderline and schizophrenic patients: a comparative study. Am J Psychiatry 1975;132:1257–1264.
Masterson JF. From Borderline Adolescent to Functioning Adult: The Test of Time. New York: Brunner/Mazel; 1980.
Pope HG, Jonas JM, Hudson JI, Cohen BM, Gunderson JG. The validity of DSM-III borderline personality disorder. Arch Gen Psychiatry 1983;40:23–30.
McGlashen TH. The Chestnut Lodge follow-up study: III. Long-term outcome of borderline personalities. Arch Gen Psychiatry 1986;43:20–30.
Paris J, Brown R, Nowlis D. Long-term follow-up of borderline patients in a general hospital. Compr Psych 1987;2:530–535.
Reich J, Nduaguba M, Yates W. Age and sex distribution of DSM-III personality cluster traits in a community population. Compr Psych, 1988;29:298–303.
Rosowsky E, Gurian B. Borderline personality disorder in late life. Int Psychogeriatr 1991;3:39–52.
Agronin M. Personality disorders in the elderly: an overview. J Geriatr Psychiatry 1994;27:151–191.
Soloff PH. Is there any drug treatment of choice for the borderline patient? Acta Psychiatr Scand Suppl 1994;379:50–55.
Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry 1988;45:111–119.
Coccaro EF, Astill JL, Herbert JL, Schut AG. Fluoxetine treatment of impulsive aggression in DSM-III-R personality disorder patients. J Clin Psychopharmacol 1990;10:373–375.
Links PS, Steiner M, Boiago I, Irwin D. Lithium therapy for borderline patients: preliminary findings. J Personal Disord 1990;4:173–181.
Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF. Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 1993;50:377–385.
Kavoussi RJ, Liu J, Coccaro EF. An open trial of sertraline in personality disorder patients with impulsive aggression. J Clin Psychiatry 1994;55:137–141.
Salzman C, Wolfson AN, Schatzberg A, et al. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 1995;15:23–29.
Markovitz PJ, Wagner SC. Venlafaxine in the treatment of borderline personality disorder. Psychopharmacol Bull 1995;31:773–777.
Rinne T, van den Brink W, Wouters I, van Dyck R. SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for females with BPD. Am J Psychiatry 2002;159:2048–2054.
Leone N. Response of borderline patients to loxapine and chlorpromazine. J Clin Psychiatry 1982;43:148–150.
Frankenburg FR, Zanarini MC. Clozapine treatment of borderline patients: a preliminary study. Compr Psychiatry 1993;34:402–405.
Khouzam HR, Donnelly NJ. Remission of self-mutilation in a patient with borderline personality during risperidone therapy. J Nerv Ment Dis 1997;185:348–349.
Chengappa KN, Ebeling T, Kang JS, Levine J, Parepally H. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. J Clin Psychiatry 1999;60:477–484.
Rocca P, Marchiaro L, Cocuzza E, Bogetto F. Treatment of borderline personality disorder with risperidone. J Clin Psychiatry 2002;63:241–244.
Zanarini MC, Frankenberg FR. Olanazapine treatment of female borderline patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry 2001;62:849–854.
Adityanjee, Schulz SC. Clinical uses of quetiapine in disease states other than schizophrenia. J Clin Psychiatry 2002;63:32–38.
Zanarini MC, Frankenburg FR, Parachini EA. A preliminary, randomized trial of fluoxetine, olanazapine, and the olanazapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry 2004;65:903–907.
Gardner DL, Cowdry RW. Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder. Am J Psychiatry 1986;143:519–522.
Stein DJ, Simeon D, Frenkel M, Islam MN, Hollander E. An open trial of valproate in borderline personality disorder. J Clin Psychiatry 1995;56:506–510.
Wilcox JA. Divalproex sodium as a treatment for borderline personality disorder. Ann Clin Psychiatry 1995;7:33–37.
Townsend MH, Cambre KM, Barbee JG. Treatment of borderline personality disorder with mood instability with divalproex sodium: series of ten cases. J Clin Psychopharmacol 2001;21:249–251.
Frankenburg FR, Zanarini MC. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind, placebo-controlled pilot study. J Clin Psychiatry 2002;63:442–446.
Gardner DL, Cowdry RW. Alprazolam induced dyscontrol in borderline personality disorder. Am J Psychiatry 1985;142:98–100.
Demopulos C, Fava M, McLean NE, Alpert JE, Nierenberg AA, Rosenbaum JF. Hypochondriacal concerns in depressed outpatients. Psychosom Med 1996;58:314–320.
Goldstein EG. Narcissistic personality disorder. In: Turner FJ, ed. Mental Health and the Elderly. New York: The Free Press; 1992.
Kahana RJ, Bibring GL. Personality types in medical management. In: Zinberg N, ed. Psychiatry and Medical Practice in a General Hospital. New York: International University Press; 1964.
Deltito JA, Stam, M. Psychopharmacological treatment of avoidant personality disorder. Compr Psych 1989;30:498–504.
Schneier FR, Chin SJ, Hollander E, Liebowitz MR. Fluoxetine in social phobia. J Clin Psychopharmacol 1992;12:62–64.
Fahlén T. Personality traits in social phobia, II: changes during drug treatment. J Clin Psychiatry 1995;56:569–573.
Vaillant GE, Perry JC. Personality disorders. In: Kaplan HI, Sadock B, eds. Comprehensive Textbook of Psychiatry, Fifth edition, vol. 2. Baltimore: Williams & Wilkins; 1990:1352–1387.
Abrams RC, Alexopoulos GS, Young RC. Geriatric depression and DSM-III-R personality disorder criteria. J Am Geriatr Soc 1987;35:383–386.
Mezzich JE, Fabrega H, Coffman GA, Glavin Y. Comprehensively diagnosing geriatric patients. Compr Psychiatry 1987;28:68–76.
Thompson LW, Gallagher D, Czirr R. Personality disorder and outcome in the treatment of late-life depression. J Geriatr Psychiatry 1988;21:133–153.
Bergmann K. Neurosis and personality disorder in old age. In: Isaacs AD, Post F, eds. Studies in Geriatrics Psychiatry. New York: Wiley; 1978:41–76.
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Third Edition, revised (DSMIII-R). Washington DC: Amer Psychiatric Pub; 1987.
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Washington DC: Amer Psychiatric Pub; 1994.
Phillips KA, Gunderson JG. Personality disorders. In: Hales RE, Yudolsky SC, Talbott JA, eds. Textbook of Psychiatry, Second Edition. Washington DC: Amer Psychiatric Pub; 1994:701–728.
Klein DN. Depressive personality: reliability, validity, and relation to dysthymia. J Abnorm Psychol 1990;99:412–421.
Agronin ME, Orr WB. Personality disorders in a geriatric psychiatry outpatient clinic. American Association for Geriatric Psychiatry—Abstracts. Annual Meeting, March 8–11, 1998, San Diego, CA.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Agronin, M.E. (2006). Personality Disorders. In: Jests, D.V., Friedman, J.H. (eds) Psychiatry for Neurologists. Current Clinical Neurology. Humana Press. https://doi.org/10.1007/978-1-59259-960-8_10
Download citation
DOI: https://doi.org/10.1007/978-1-59259-960-8_10
Publisher Name: Humana Press
Print ISBN: 978-1-58829-483-8
Online ISBN: 978-1-59259-960-8
eBook Packages: MedicineMedicine (R0)